| |
Dear Reader,
Take a look at this photo…
It was taken from the roof of one of the top cancer centers in the world.
That machine that's being lowered inside?
It could help as many as 800,000 American cancer patients per year -- that's 50% of the 1.6 million people diagnosed every year.
You see, in recent months, one little-known company has developed a device so powerful it can diagnose and zap cancer from your body in a single hour.
It's a breakthrough our 20-year expert, Dave Lashmet is calling, "the biggest cancer discovery in his career."
He says, "[This breakthrough] could mean, half the people who get an almost certain death sentence today live to laugh about it, after a game of golf."
Dave's also certain that the stock of the little-known company will skyrocket once it wins global regulatory approval in the coming weeks.
Click here to see why… and what Dave's doing this week to spread the message.
Sincerely,
Justin Brill
Editor, The Stansberry Digest
P.S. We checked The Wall Street Journal, the Financial Times, Barron's, Forbes and even the New England Journal of Medicine. No one (but us) is covering this story yet. To learn how to take a stake in the little-known company that will revolutionize cancer treatment, click here now. |
|
| |
All contents of this e-mail are copyright 2017 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.
DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.
You're receiving this email at [email protected]. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to [email protected].
To unsubscribe from this mailing, click here: Unsubscribe
|
|
|
